Literature DB >> 16209862

Congenital cytomegalovirus infection and hearing loss.

Robert F Pass1.   

Abstract

Sensorineural hearing loss is the most frequent sequela of congenital cytomegalovirus (CMV) infection, and epidemiological evidence also suggests that congenital CMV infection is responsible for a substantial proportion of sensorineural hearing loss in children. Hearing loss due to congenital CMV infection can be present at birth or can appear later, usually during the first year of life; it usually worsens as the infant or child ages. Follow-up of children with congenital CMV infection should include repeated audiological testing. Based on the benefits of early detection of hearing loss, one could propose screening all infants for congenital CMV infection so that those with hearing impairment can be identified as early as possible by appropriate audiological follow-up. Antiviral treatment that could improve hearing outcome, with a safety profile suitable for use in minimally ill infants, would clearly increase the benefit of universal screening for congenital CMV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209862

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  19 in total

Review 1.  Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Authors:  Mark R Schleiss; Sallie R Permar; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

2.  Murine model for congenital CMV infection and hearing impairment.

Authors:  Chen Juanjuan; Feng Yan; Chen Li; Liu Haizhi; Wang Ling; Wang Xinrong; Xiao Juan; Liu Tao; Yin Zongzhi; Chen Suhua
Journal:  Virol J       Date:  2011-02-15       Impact factor: 4.099

3.  Congenital cytomegalovirus infection: update on management strategies.

Authors:  Mark R Schleiss
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

4.  The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.

Authors:  Elisabeth A Pitt; Pranay Dogra; Ravi S Patel; Angela Williams; Jonathan S Wall; Tim E Sparer
Journal:  Antiviral Res       Date:  2016-09-25       Impact factor: 5.970

5.  Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein.

Authors:  J Lewis Stern; John Z Cao; Jiake Xu; Edward S Mocarski; Barry Slobedman
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

Review 6.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  A model of human cytomegalovirus infection in severe combined immunodeficient mice.

Authors:  Fernando J Bravo; Rhonda D Cardin; David I Bernstein
Journal:  Antiviral Res       Date:  2007-07-10       Impact factor: 5.970

8.  The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.

Authors:  Ivana Nemčovičová; Dirk M Zajonc
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-22

9.  Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.

Authors:  Mark R Schleiss; Michael A McVoy
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

10.  The Neonatal CD8+ T Cell Repertoire Rapidly Diversifies during Persistent Viral Infection.

Authors:  Vanessa Venturi; Kito Nzingha; Timothy G Amos; Wisler C Charles; Iryna Dekhtiarenko; Luka Cicin-Sain; Miles P Davenport; Brian D Rudd
Journal:  J Immunol       Date:  2016-01-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.